Tracked metric

BCI private funding

Disclosed cumulative private funding of leading BCI developers — how seriously capital backs the field. Neuralink raised a $650M Series E in 2025 at a reported $9B valuation; ~$1.3B cumulative.

$1.3BReached · Jun 2025

View on the tracker

0.49 USD Mar 2026 Science Corporation Press · 2026-03
1.3 USD 2025 Neuralink Press · 2025-06
0.33 USD 2025 Synchron Press · 2025-11
0.11 USD 2025 Paradromics Press · 2025-06
0.155 USD 2025 Precision Neuroscience Press · 2025-04
0.6 USD 2023 Neuralink Press · 2025-06

More on this

Analysis as of May 27, 2026

Is BCI funding ahead of the medicine?

by Frontier Milestones

A $9B valuation for Neuralink prices in a future where brain implants are routine — but today's devices help a few dozen people in trials. Our read on the gap between capital and clinical reality. (Our opinion, not investment advice.)

Our read — labelled opinion, not investment advice.

Brain-Computer Interfaces

Read